Autoimmune haemolytic anaemia - A practical guide to cope with a diagnosticand therapeutic challenge

Netherlands Journal of Medicine

Volumn 69, Issue 4, 2011, Pages 177-184

  Zeerleder, S ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autoantibodies; Autoimmune hemolytic anemia; Cold autoantibodies; Complement; Hemolysis; Warm autoantibodies

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ECULIZUMAB; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ALGORITHM; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; COOMBS TEST; DIAGNOSTIC ERROR; ERYTHROCYTE; HEART FUNCTION; HEMOLYSIS; INTRAVASCULAR HEMOLYSIS; LABORATORY TEST; MONOTHERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; SPLENECTOMY;

ADRENAL CORTEX HORMONES; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIBODIES; BLOOD TRANSFUSION; CYTOTOXINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

EID: 79955703187     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Packman CH. Hemolytic anemia due to warm autoantibodies. Blood Rev. 2008 January;22(1):17-31.
2. Engelfriet CP, van tVeer MB, Maas N, Ouwehand WH, Beckers DO, von den Borne AEG. Autoimmune haemolytic anemias. In: Kay AB, Denman AM, Wright R, editors. Clinical Immunology and Allergy. London: Baillieres Tindall;1987:251-267.
3. Jeffries M, Hamadeh F, Aberle T, Glenn S, Kamen DL, Kelly JA, et al. Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective. Lupus 2008 August;17(8):739-743.
4. Nossent JC, Swaak AJ. Prevalence and signifcance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med. 1991 July;80(291):605-612.
5. Arndt PA, Leger RM, Garratty G. Serologic fndings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies. Transfusion. 2009 February;49(2):235-242.
6. Petz LD. Cold antibody autoimmune hemolytic anemias. Blood Rev. 2008 January;22(1):1-15.
7. LoBuglio AF, Cotran RS, Jandl JH. Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science. 1967 December 22;158(808):1582-1585.
8. Petz LD. Diagnostic complexities in autoimmune hemolytic anemias. Transfusion. 2009 February;49(2):202-203.
9. Bardill B, Mengis C, Tschopp M, Wuillemin WA. Severe IgA-mediated auto-immune haemolytic anaemia in a 48-yr-old woman. Eur J Haematol. 2003 January;70(1):60-63.
10. Engelfriet CP, Reesink HW, Garratty G, Knight R, de SM, Contreras M, et al. The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemia. Vox Sang. 2000;78(3):200-207.
11. Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion. 2009 March;49(3):453-457.
12. Evans RS, Bingham M, Boehni P. Autoimmune hemolytic disease. Antibody dissociation and activity. Arch Intern Med. 1961 September;108:338-352.
13. Fries LF, Brickman CM, Frank MM. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J Immunol. 1983 September;131(3):1240-1245.
14. Schreiber AD, Parsons J, McDermott P, Cooper RA. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest. 1975 November;56(5):1189-1197.
15. Allgood JW, Chaplin H, Jr. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med. 1967 August;43(2):254-273.
16. Meyer O, Stahl D, Beckhove P, Huhn D, Salama A. Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type. Br J Haematol. 1997 September;98(4):860-862.
17. Serrano J. [Autoimmune hemolytic anemia. Review of 200 cases studied in a period of 20 years (1970-1989)]. Sangre. 1992 August;37(4):265-274.
18. Zupanska B, Sylwestrowicz T, Pawelski S. The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia. 1981 December;14(4):425-433.
19. Sakalova A, Hrubisko M. [Cyclophosphamide in the treatment of immune hemocytopenias]. Folia Haematol Int Mag Klin Morphol. 1975;102(5):559-564.
20. Worlledge SM, Brain MC, Cooper AC, Hobbs JR, Dacie JV. Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med. 1968 December 12;61(12):1312-1315.
21. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood. 2002 July 15;100(2):704-706.
22. Shvidel L, Sigler E, Shtalrid M, Berrebi A. Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures. Am J Hematol. 2006 June;81(6):423-425.
23. Emilia G, Messora C, Longo G, Bertesi M. Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol. 1996;93(2):341-344.
24. Howard J, Hoffbrand AV, Prentice HG, Mehta A. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. Br J Haematol. 2002 June;117(3):712-715.
25. Allgood JW, Chaplin H, Jr. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med. 1967 August;43(2):254-273.
26. Cherthow G, Dacie JV. Results of splenectomy in auto-immune haemolytic anaemia. Br J Haematol. 1956 July;2(3):237-249.
27. Coon WW. Splenectomy in the treatment of hemolytic anemia. Arch Surg. 1985 May;120(5):625-628.
28. Casaccia M, Torelli P, Squarcia S, Sormani MP, Savelli A, Troilo B, et al. Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS). Surg Endosc. 2006 August;20(8):1214-1220.
29. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 November 1;104(9):2623-2634.
30. Yong M, Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, et al. Mortality risk in splenectomised patients: a Danish population-based cohort study. Eur J Intern Med. 2010 February;21(1):12-6.
31. Thomsen RW, Schoonen WM, Farkas DK, Riis A, Jacobsen J, Fryzek JP, et al. Risk for hospital contact with infection in patients with splenectomy: a population-based cohort study. Ann Intern Med. 2009 October 20;151(8):546-555.
32. Ejstrud P, Kristensen B, Hansen JB, Madsen KM, Schonheyder HC, Sorensen HT. Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis. 2000;32(5):521-525.
33. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994 January 15;83(2):435-445.
34. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol. 2008 April;141(2):149-169.
35. Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, et al. Effcacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Am J Hematol. 2009 March;84(3):153-157.
36. Dierickx D, Verhoef G, Van HA, Mineur P, Roest A, Triffet A, et al. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. J Intern Med. 2009 November;266(5):484-491.
37. Narat S, Gandla J, Hoffbrand AV, Hughes RG, Mehta AB. Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica. 2005 September;90(9):1273-1274.
38. Shanafelt TD, Madueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc. 2003 November;78(11):1340-1346.
39. Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14;113(20):4834-4840.
40. Majer RV, Hyde RD. High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia. Clin Lab Haematol. 1988;10(4):391-395.
41. Dausset J, Colombani J. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood. 1959 December;14:1280-1301.
42. Firkin BG, Blackwell JB, Johnston GA. Essential eryoglobulinaemia and acquired haemolytic anaemia due to cold agglutinins. Australas Ann Med. 1959 May;8(2):151-157.
43. Pisciotta AV. Cold hemagglutination in acute and chronic hemolytic syndromes. Blood. 1955 April;10(4):295-311.
44. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood. 2004 April 15;103(8):2925-2928.
45. Schollkopf C, Kjeldsen L, Bjerrum OW, Mourits-Andersen HT, Nielsen JL, Christensen BE, et al. Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma. 2006 February;47(2):253-260.
46. Siami FS, Siami GA. A last resort modality using cryofltration apheresis for the treatment of cold hemagglutinin disease in a Veterans Administration hospital. Ther Apher Dial. 2004 October;8(5):398-403.
47. Roth A, Huttmann A, Rother RP, Duhrsen U, Philipp T. Long-term effcacy of the complement inhibitor eculizumab in cold agglutinin disease. Blood. 2009 April 16;113(16):3885-3886.